Greenwich LifeSciences, Inc.
$15.63
-$0.46 (-2.86%)
$15.35Day Range$16.37
Key Statistics
Market Cap
$229.42M
Shares Outstanding
14.7M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Sep 25, 2020
Round Lot
100
Locale
US
Trading Data
Day Open
$16.09
Day High
$16.37
Day Low
$15.35
Volume
121.7K
VWAP
$15.80
Prev Close
$16.09
Transactions
--
Acc. Volume
--
About Greenwich LifeSciences, Inc.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9-amino-acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including breast cancers at low (1+), intermediate (2+), and high (3+ or overexpressing) levels.
PHARMACEUTICAL PREPARATIONSSIC 283413 employees3992 BLUEBONNET DR, BUILDING 14, STAFFORD, TX, 77477203-434-3290IPO Sep 25, 2020US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001799788
- Composite FIGI
- BBG00V6PT8C7
- Share Class FIGI
- BBG00V6PT8D6
- Ticker Root
- GLSI
- SIC Code
- 2834
About Greenwich LifeSciences, Inc. (GLSI) Stock
Greenwich LifeSciences, Inc. (GLSI) closed the 2026-09-16 session at $15.63, down 2.86% versus the previous close (-0.46). The stock opened at $16.09 and traded between $15.35 and $16.37 during that session. Session trading volume was 122K shares. The volume-weighted average price (VWAP) is $15.80.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9-amino-acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including breast cancers at low (1+), intermediate (2+), and high (3+ or overexpressing) levels.
Greenwich LifeSciences, Inc. has a market capitalization of $229.4 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. GLSI is listed on the XNAS exchange. The company employs approximately 13 people. Greenwich LifeSciences, Inc. is headquartered in STAFFORD, TX. The recorded listing date is 2020-09-25.
On this page you can find market GLSI stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.